Abstract
Get full access to this article
View all access options for this article.
References
1.
Reidenberg M.M.
,
Conner B.A.
Counterfeit and substandard drugs. Clin Pharmacol Ther. 2001 ; 69 (4 ): 189 –93 .
2.Pharmaceutical Security Institute. http://www.psi-inc.org/. Accessed December 8, 2002.
3.
Csillag C.
Epidemic of counterfeit drugs causes concern in Brazil. Lancet. 1998 ; 352 : 553 .
4.
Petralanda I.
Quality of antimalarial drugs and resistance to plasmodium vivax in Amazonian region. Lancet. 1995 ; 345 : 1437 .
5.
Newton P.N.
,
White N.J.
,
Rozendaal J.A.
Murder by fake drugs: Time for international action. BMJ. 2002 ; 324 : 800 –1 .
6.
Rittenburg J.H.
Fake drugs: A clear and present danger. www.biocode.com. May 2002. www.biocode.com/html/profiles/apps/JHR%20PMPS%2028May2002.pdf. Accessed December 8, 2002.
7.Thousands of counterfeit OxyContin tablets seized by US Customs Service. PRNewswire.com. December 4, 2002 . www.prnewswire.com. Accessed December 4, 2002.
8.
Neergaard L.
US officials scrambling to fight counterfeit medicine. Chicago Tribune. June 18, 2002 . www.dmdoptions.com/counterfeit%20medicine.htm. Accessed on December 2, 2002.
9.Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements, and Administrative Procedures; Delay of Effective Date. Federal Register. 2002 ; 67 (30 ): 6645 .